Johnson & Johnson's quarterly profit rises 3.3 pct
July 17, 2018 at 06:46 AM EDT
Johnson & Johnson reported a 3.3 percent rise in quarterly profit on Tuesday, as higher sales of cancer drugs Zytiga and Darzalex helped offset pressure on its blockbuster rheumatoid arthritis treatment Remicade.
